Unknown

Dataset Information

0

Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.


ABSTRACT: PURPOSE:The eukaryotic translation initiation factor complex 4E (eIF4E) is downstream in the mammalian target of rapamycin (mTOR) pathway. This study explored expression of eIF4E and its relationship with the PTEN/AKT and RAS/MEK/ERK pathways in non-small cell lung carcinoma (NSCLC). EXPERIMENTAL DESIGN:The status of phosphorylated eIF4E (p-eIF4E), phosphorylated AKT (p-AKT), PTEN, phosphorylated tuberin (p-TSC2), phosphorylated mTOR (p-mTOR), phosphorylated S6 (p-S6), and phosphorylated Erk1/2 (p-Erk1/2) was studied using immunohistochemical analysis applied to a tissue microarray containing 300 NSCLCs. Staining results for each antibody were compared with clinical and pathologic features, and the relationship between staining results was explored. RESULTS:Overexpression of p-eIF4E, p-AKT, p-TSC2, p-mTOR, p-S6, and p-Erk1/2 in NSCLC was found in 39.9%, 78.8%, 5.1%, 46.7%, 27.1%, and 16.6% of tumors, respectively. The phenotype of p-eIF4E correlated positively with that of p-AKT, p-TSC2, and p-S6 (P < 0.001). Overall survival in NSCLC patients was significantly shorter in cases with overexpression of p-eIF4E and p-AKT alone and in combination (log-rank P < 0.001, each). Cases with underexpression of PTEN were limited (6.4%), and this phenotype did not correlate with any clinical variable. In cluster analysis, the p-AKT/p-mTOR/p-eIF4E/p-S6-positive group had significantly shorter survival compared with the survival of all cases (P < 0.001). Multivariate analysis showed that p-eIF4E overexpression is an independent prognostic factor for NSCLC (P = 0.004). CONCLUSIONS:This study shows that p-eIF4E expression in addition to p-AKT predicts poor prognosis in NSCLC. Moreover, the correlation between expression of p-eIF4E with p-AKT, as well as p-TSC2 and p-S6, indicates that eIF4E activation through the AKT pathway plays an important role in the progression of NSCLC.

SUBMITTER: Yoshizawa A 

PROVIDER: S-EPMC7581274 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

Yoshizawa Akihiko A   Fukuoka Junya J   Shimizu Shigeki S   Shilo Konstantin K   Franks Teri J TJ   Hewitt Stephen M SM   Fujii Takeshi T   Cordon-Cardo Carlos C   Jen Jin J   Travis William D WD  

Clinical cancer research : an official journal of the American Association for Cancer Research 20091215 1


<h4>Purpose</h4>The eukaryotic translation initiation factor complex 4E (eIF4E) is downstream in the mammalian target of rapamycin (mTOR) pathway. This study explored expression of eIF4E and its relationship with the PTEN/AKT and RAS/MEK/ERK pathways in non-small cell lung carcinoma (NSCLC).<h4>Experimental design</h4>The status of phosphorylated eIF4E (p-eIF4E), phosphorylated AKT (p-AKT), PTEN, phosphorylated tuberin (p-TSC2), phosphorylated mTOR (p-mTOR), phosphorylated S6 (p-S6), and phospho  ...[more]

Similar Datasets

| S-EPMC7001968 | biostudies-literature
| S-EPMC5108768 | biostudies-literature
| S-EPMC2573464 | biostudies-literature
| S-EPMC9254468 | biostudies-literature
| S-EPMC7297025 | biostudies-literature
| S-EPMC5053688 | biostudies-literature
| S-EPMC9223369 | biostudies-literature
| S-EPMC7987990 | biostudies-literature
| S-EPMC3891871 | biostudies-other
| S-EPMC6297856 | biostudies-literature